Skip to main content

Table 4 Analysis of NLR in general population

From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Group NLR
ESCC patients 3.23
238 cases 1.66
818 cases  
All 1.61
Age
   < 60 1.64
  ≥ 60 1.51
Sex
 Male 1.64
 Female 1.58